NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  CoreWeave, Inc. ("CoreWeave" or the "Company") (NASDAQ: CRWV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether CoreWeave and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On November 10, 20 ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Alaska Air Group and its officers or directors [1] Group 1: Company Investigation - Pomerantz LLP is representing investors of Alaska Air Group, indicating possible legal issues related to securities fraud [1] - The investigation follows a significant IT outage that led to a systemwide ground stop for Alaska and Horizon Air flights, resulting in operational disruptions [2] Group 2: Stock Market Reaction - Following the announcement of the IT outage, Alaska Air's stock price dropped by $2.86, or 6.13%, closing at $43.77 per share on October 24, 2025 [2]

Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of HelloFresh SE regarding potential securities fraud and unlawful business practices by the company and its executives [1]. Group 1: Allegations and Investigations - Grizzly Research published a report on November 6, 2025, alleging that HelloFresh's business is in sharp decline, with management prioritizing self-enrichment over shareholder interests [2]. - The report claims that customer demand has decreased, while the CEO has extracted cash by using HelloFresh shares as collateral for personal bank loans related to real estate investments managed by his brother [2]. Group 2: Market Reaction - Following the publication of the report, HelloFresh's stock price fell by $0.11 per share, or 6.3%, closing at $1.65 per share on November 6, 2025 [3].

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Bicycle Therapeutics plc regarding potential securities fraud or unlawful business practices [1] - RBC Capital Markets analyst downgraded Bicycle to Sector Perform from Outperform due to delays in the development of zelenectide pevedotin for metastatic urothelial cancer, which is now pushed to the first quarter of 2026 [2] - Following the downgrade, Bicycle's ADR price fell by $0.69, or 7.88%, closing at $8.07 on October 31, 2025 [3] Company Developments - The investigation by Pomerantz LLP focuses on whether Bicycle and its officers/directors have engaged in any fraudulent activities [1] - The delay in the development of zelenectide pevedotin is significant as the urothelial cancer treatment market is becoming increasingly competitive, with potential advantages for competing products, particularly from Pfizer [2] - The recent downgrade and subsequent price drop indicate investor concerns regarding Bicycle's market position and product development timeline [3]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential derivative claims on behalf of aTyr Pharma, Inc. related to alleged fiduciary breaches concerning the Phase 3 EFZO-FIT clinical trial disclosures [1][2] Investigation Background - The investigation covers the period from November 7, 2024, to September 12, 2025, focusing on allegations that aTyr and certain executives made false and/or misleading statements regarding the Phase 3 trial results [2][3] - Following the negative results from the Phase 3 trial, aTyr's stock price experienced a significant decline [2] Board Oversight - The investigation is examining whether aTyr's board failed to adequately oversee clinical disclosure controls and allowed overly optimistic representations that could expose the company to litigation and reputational risks [3] Shareholder Guidance - Current aTyr shareholders who held their shares continuously before November 7, 2024, may have the standing to pursue derivative claims on behalf of the company [2]

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - James Hardie Industries is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Allegations of Fraud - The lawsuit claims that James Hardie misrepresented the strength and momentum of its North American fiber cement segment, asserting that sales were driven by sustainable customer demand, while in reality, they were the result of inventory loading by channel partners, indicative of fraudulent channel stuffing [5]. Stock Performance and Impact - On August 19, 2025, James Hardie reported a 12% decline in North American fiber cement sales, revealing that customers were destocking to return to normal inventory levels. This announcement led to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [6]. Management Changes - On November 17, 2025, it was announced that Rachel Wilson would step down from her role as CFO of James Hardie [7].

Core Viewpoint - The article discusses a securities class action lawsuit against CarMax, Inc. (NYSE: KMX), highlighting the approaching Lead Plaintiff Deadline of January 2, 2026, and urging affected investors to contact the law firm Hagens Berman for potential participation in the case [1][5]. Summary by Sections Lawsuit Allegations - The lawsuit claims that CarMax and its executives misled investors regarding the stability and growth prospects of the business, resulting in significant stock declines of 44% following a disappointing earnings report and the unexpected termination of the CEO [2][4]. Class Period - The class period for the lawsuit is defined as June 20, 2025, to November 5, 2025, during which investors purchased CarMax securities [3]. Key Issues Highlighted - The complaint identifies two main undisclosed issues that allegedly inflated the stock price: - **Unsustainable Demand**: CarMax reportedly misrepresented Q1 2026 growth as being robust while failing to disclose that it was driven by a temporary surge in customer demand due to anticipated tariffs [4]. - **CarMax Auto Finance Risk**: Management assured investors about the stability of their loan reserves, which later revealed a significant increase in loan loss provisions amounting to $142 million, indicating high default risks [4]. Impact on Business - The lawsuit outlines the adverse impacts on CarMax's business, including: - A 24% decline in net EPS and a 40% sequential increase in loan loss provisions announced on September 25, 2025, leading to a 20% drop in stock price [4]. - The CEO's termination and a drastic cut in forward guidance, signaling systemic weaknesses in business operations [4]. Call to Action - Hagens Berman emphasizes the importance of the January 2nd deadline for investors seeking a leadership role in the lawsuit, encouraging those who suffered losses to reach out for assistance [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Blue Owl Capital Inc. securities, alleging misleading statements and undisclosed liquidity issues during the class period from February 6, 2025, to November 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Blue Owl faced significant pressure on its asset base due to business development companies (BDC) redemptions, leading to undisclosed liquidity issues [5]. - Defendants allegedly downplayed the severity of the negative impacts on Blue Owl's business, operations, and prospects, resulting in materially misleading statements [5]. - Investors are encouraged to join the class action to seek compensation without out-of-pocket fees through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Jayud Global Logistics Limited ("Jayud†or the "Company†) (NASDAQ: JYD) securities between April 21, 2023 and April 30, 2025, inclusive (the "Class Period†). Jayud investors have until January 20, 2026 to file a lead plaintiff motion. Law Offices of Frank R. Cruz Encourages Jayud Global Logistics Limited (JYD) Shareholders To Inquire About Securities ...

LOS ANGELES, Dec. 10, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE), CLICK HERE BEFORE JANUARY 26, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.  What Is The Lawsuit Abou ...